Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CKAP4 inhibitors(cytoskeleton associated protein 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometrial Carcinoma | Preclinical | Netherlands | 29 Apr 2025 | |
Endometrial Carcinoma | Preclinical | Netherlands | 29 Apr 2025 | |
Endometrial Carcinoma | Preclinical | Switzerland | 29 Apr 2025 | |
Endometrial Carcinoma | Preclinical | Sweden | 29 Apr 2025 | |
Endometrial Carcinoma | Preclinical | Germany | 29 Apr 2025 | |
Endometrial Carcinoma | Preclinical | United Kingdom | 29 Apr 2025 | |
Ovarian Cancer | Preclinical | United Kingdom | 29 Apr 2025 | |
Ovarian Cancer | Preclinical | Switzerland | 29 Apr 2025 | |
Ovarian Cancer | Preclinical | Netherlands | 29 Apr 2025 | |
Ovarian Cancer | Preclinical | Sweden | 29 Apr 2025 |